Financiere de Tubize SA
LSE:0D53
Financiere de Tubize SA
LSE:0D53
Price:
219
EUR
-2.45%
Market Closed
Market Cap:
€110.6m
Relative Value
The Relative Value of one
0D53
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 219 EUR,
Financiere de Tubize SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0D53 Relative Value
HIDDEN
Multiples Across Competitors
0D53 Competitors Multiples
Financiere de Tubize SA Competitors
Financiere de Tubize SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BE |
|
Financiere de Tubize SA
LSE:0D53
|
9.7B EUR | 0 | 104.6 | -3 703.3 | -3 703.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
923.3B USD | 14.2 | 44.7 | 30.2 | 32.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
582.8B USD | 6.2 | 21.7 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
253.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.8B CHF | 5.3 | 21.4 | 13.2 | 17 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.8B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.7B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.7B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
